MM-121
Product
Merrimack Pharmaceuticals, Inc.
Total Payments
$105,233
Transactions
19
Doctors
0
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2017 | $105,233 | 19 | 0 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $105,233 | 19 | 100.0% |
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| MM-121-01-02-09 | Merrimack Pharmaceuticals, Inc. | $105,233 | 0 |
Top Doctors Receiving Payments for MM-121
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | Boston, MA | $105,233 | 19 |
Ad
Manufacturing Companies
- Merrimack Pharmaceuticals, Inc. $105,233
Product Information
- Type Product
- Total Payments $105,233
- Total Doctors 0
- Transactions 19
About MM-121
MM-121 is a product associated with $105,233 in payments to 0 healthcare providers, recorded across 19 transactions in the CMS Open Payments database. The primary manufacturer is Merrimack Pharmaceuticals, Inc..
Payment data is available from 2017 to 2017. In 2017, $105,233 was paid across 19 transactions to 0 doctors.
The most common payment nature for MM-121 is "Unspecified" ($105,233, 100.0% of total).
MM-121 is associated with 1 research study, including "MM-121-01-02-09" ($105,233).